Related references
Note: Only part of the references are listed.Safety of Inactivated Influenza Vaccine in Cancer Patients Receiving Immune Checkpoint Inhibitors
Curtis R. Chong et al.
CLINICAL INFECTIOUS DISEASES (2020)
Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer
Oliver A. Cornely et al.
OPEN FORUM INFECTIOUS DISEASES (2020)
How I treat CMV reactivation after allogeneic hematopoietic stem cell transplantation
Hermann Einsele et al.
BLOOD (2020)
Case Fatality Rate of Cancer Patients with COVID-19 in a New York Hospital System
Vikas Mehta et al.
CANCER DISCOVERY (2020)
How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies
Joshua A. Hill et al.
BLOOD (2020)
Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study
Wedad B. Awad et al.
BMC INFECTIOUS DISEASES (2020)
Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium difficile Infection in Allogeneic Hematopoietic Cell Transplant Recipients
Alex Ganetsky et al.
CLINICAL INFECTIOUS DISEASES (2019)
Summary of Maribavir (SHP620) Drug–Drug Interactions Based on Accumulated Clinical and Nonclinical Data
Ivy Song et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
A Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial of Oral Brincidofovir for Cytomegalovirus Prophylaxis in Allogeneic Hematopoietic Cell Transplantation
Francisco M. Marty et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European Conference on Infections in Leukaemia (ECIL 7)
Per Ljungman et al.
LANCET INFECTIOUS DISEASES (2019)
Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review
Guy El Helou et al.
INFECTION AND DRUG RESISTANCE (2019)
Resistant or refractory cytomegalovirus infections after hematopoietic cell transplantation: diagnosis and management
Fareed Khawaja et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Is antimicrobial prophylaxis necessary for lymphoma patients? A single centre, real-life experience
Abdulkerim Yildiz et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)
Oral Vancomycin for Secondary Prophylaxis of Clostridium difficile Infection
Chase C. Brown et al.
ANNALS OF PHARMACOTHERAPY (2019)
Prolonged oral vancomycin for secondary prophylaxis of relapsing Clostridium difficile infection
Kevin Zhang et al.
BMC INFECTIOUS DISEASES (2019)
Azole antifungals and new targeted therapies for hematological malignancy
Julian Lindsay et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2019)
Cytomegalovirus infection in hematologic malignancy settings other than the allogeneic transplant
F. Marchesi et al.
HEMATOLOGICAL ONCOLOGY (2018)
Serious Infections in Patients Receiving Ibrutinib for Treatment of Lymphoid Cancer
Tilly Varughese et al.
CLINICAL INFECTIOUS DISEASES (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
L. Clifford McDonald et al.
CLINICAL INFECTIOUS DISEASES (2018)
Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline
A. J. Ullmann et al.
CLINICAL MICROBIOLOGY AND INFECTION (2018)
New Developments in the Management of Cytomegalovirus Infection After Transplantation
Atibordee Meesing et al.
DRUGS (2018)
The Third International Consensus Guidelines on the Management of Cytomegalovirus in Solid-organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2018)
Seasonal influenza vaccine in immunocompromised persons
Mohammad Bosaeed et al.
HUMAN VACCINES & IMMUNOTHERAPEUTICS (2018)
Antimicrobial Prophylaxis for Adult Patients With Cancer-Related Immunosuppression: ASCO and IDSA Clinical Practice Guideline Update
Randy A. Taplitz et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Clostridioides difficile Infection
Alice Y. Guh et al.
ANNALS OF INTERNAL MEDICINE (2018)
Risk, Outcomes, and Predictors of Clostridium difficile Infection in Lymphoma: A Nationwide Study
Sanjay Bhandari et al.
SOUTHERN MEDICAL JOURNAL (2018)
Management of Hepatitis B Virus Infection: 2018 Guidelines from the Canadian Association for the Study of the Liver and Association of Medical Microbiology and Infectious Disease Canada
Carla S. Coffin et al.
CANADIAN LIVER JOURNAL (2018)
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
F. M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection
M. H. Wilcox et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
The 2016 revision of the World Health Organization classification of lymphoid neoplasms
Steven H. Swerdlow et al.
BLOOD (2016)
Are We There Yet? Impact of the First International Standard for Cytomegalovirus DNA on the Harmonization of Results Reported on Plasma Samples
Jutta K. Preiksaitis et al.
CLINICAL INFECTIOUS DISEASES (2016)
The Spectrum of Serious Infections Among Patients Receiving Immune Checkpoint Blockade for the Treatment of Melanoma
Maria Del Castillo et al.
CLINICAL INFECTIOUS DISEASES (2016)
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients
Johan Maertens et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Alternatives to antibiotics-a pipeline portfolio review
Lloyd Czaplewski et al.
LANCET INFECTIOUS DISEASES (2016)
Cryptococcus neoformans infection in malignancy
Sarah A. Schmalzle et al.
MYCOSES (2016)
Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over-the-counter probiotic formulations
S. A. Cohen et al.
TRANSPLANT INFECTIOUS DISEASE (2016)
Improved immunogenicity of high-dose influenza vaccine compared to standard-dose influenza vaccine in adult oncology patients younger than 65 years receiving chemotherapy: A pilot randomized clinical trial
Saad Jamshed et al.
VACCINE (2016)
Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection
Hana Hakim et al.
VACCINE (2016)
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies treated with anticancer therapy
Man Fai Law et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection
G. Cammarota et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)
Preventing Hepatitis B Reactivation Due to Immunosuppressive Drug Treatments
Robert P. Perrillo et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2015)
Hepatitis B Virus Screening for Patients With Cancer Before Therapy: American Society of Clinical Oncology Provisional Clinical Opinion Update
Jessica P. Hwang et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Prediction of Serious Complications in Patients With Seemingly Stable Febrile Neutropenia: Validation of the Clinical Index of Stable Febrile Neutropenia in a Prospective Cohort of Patients From the FINITE Study
Alberto Carmona-Bayonas et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
ASCO Provisional Clinical Opinion for Hepatitis B Virus Screening Before Cancer Therapy: Are These the Right Tests in the Right Patients?
Lisa K. Hicks et al.
JOURNAL OF ONCOLOGY PRACTICE (2015)
Invasive fungal infections in lymphoproliferative disorders: a monocentric retrospective experience
Anna Maria Nosari et al.
LEUKEMIA & LYMPHOMA (2014)
CMV Prophylaxis in Hematopoietic-Cell Transplantation
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Hema e-Chart Registry of invasive fungal infections in haematological patients: improved outcome in recent years in mould infections
A. M. Nosari et al.
CLINICAL MICROBIOLOGY AND INFECTION (2013)
Randomized Controlled Trial of Entecavir Prophylaxis for Rituximab-Associated Hepatitis B Virus Reactivation in Patients With Lymphoma and Resolved Hepatitis B
Yi-Hsiang Huang et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
CMX001 to Prevent Cytomegalovirus Disease in Hematopoietic-Cell Transplantation
Francisco M. Marty et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
Els van Nood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease
B. Guo et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Survival in neutropenic patients with severe sepsis or septic shock
Matthieu Legrand et al.
CRITICAL CARE MEDICINE (2012)
Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry
William J. Steinbach et al.
JOURNAL OF INFECTION (2012)
Cryptococcus gattii: where do we go from here?
Julie Harris et al.
MEDICAL MYCOLOGY (2012)
A single-center, prospective and randomized controlled study: Can the prophylactic use of lamivudine prevent hepatitis B virus reactivation in hepatitis B s-antigen seropositive breast cancer patients during chemotherapy?
Meijun Long et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Cryptococcus gattii in the United States: Clinical Aspects of Infection With an Emerging Pathogen
J. R. Harris et al.
CLINICAL INFECTIOUS DISEASES (2011)
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients
Livio Pagano et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Cryptococcus gattii: a resurgent fungal pathogen
Vishnu Chaturvedi et al.
TRENDS IN MICROBIOLOGY (2011)
Risk Factors for Cryptococcus gattii Infection, British Columbia, Canada
Laura MacDougall et al.
EMERGING INFECTIOUS DISEASES (2011)
In Vitro and In Vivo Activities of the Novel Anticytomegalovirus Compound AIC246
Peter Lischka et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Prospective Surveillance for Invasive Fungal Infections in Hematopoietic Stem Cell Transplant Recipients, 2001-2006: Overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database
Dimitrios P. Kontoyiannis et al.
CLINICAL INFECTIOUS DISEASES (2010)
Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America
John R. Perfect et al.
CLINICAL INFECTIOUS DISEASES (2010)
Update on New Antivirals Under Development for the Treatment of Double-Stranded DNA Virus Infections
L. K. Dropulic et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study
Livio Pagano et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2010)
Cytomegalovirus in Hematopoietic Stem Cell Transplant Recipients
Per Ljungman et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2010)
Utility of Influenza Vaccination for Oncology Patients
Daniel A. Pollyea et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Fecal bacteriotherapy for recurrent Clostridium difficile infection
Johan S. Bakken
ANAEROBE (2009)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia
J. Styczynski et al.
BONE MARROW TRANSPLANTATION (2009)
Fungal infection prevention after hematopoietic cell transplantation
K. A. Marr et al.
BONE MARROW TRANSPLANTATION (2009)
Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
D. Neofytos et al.
CLINICAL INFECTIOUS DISEASES (2009)
Effect of prophylactic lamivudine for chemotherapy-associated hepatitis B reactivation in lymphoma: a meta-analysis of published clinical trials and a decision tree addressing prolonged prophylaxis and maintenance
Panayiotis D. Ziakas et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2009)
Influenza in immunosuppressed populations: a review of infection frequency, morbidity, mortality, and vaccine responses
Ken M. Kunisaki et al.
LANCET INFECTIOUS DISEASES (2009)
Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study
Drew J. Winston et al.
BLOOD (2008)
Management of CMV, HHV-6, HHV-7 and Kaposi-sarcoma herpesvirus (HHV-8) infections in patients with hematological malignancies and after SCT
P. Ljungman et al.
BONE MARROW TRANSPLANTATION (2008)
Valganciclovir prevents cytomegalovirus reactivation in patients receiving alemtuzumab-based therapy
Susan O'Brien et al.
BLOOD (2008)
Fungal infections in recipients of hematopoietic stem cell transplants: Results of the SEIFEM B-2004 study - Sorveglianza epidemiologica infezioni fungine nelle emopatie maligne
L. Pagano et al.
CLINICAL INFECTIOUS DISEASES (2007)
Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet
W. Lawrence Drew et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours
M. S. Aapro et al.
EUROPEAN JOURNAL OF CANCER (2006)
Mortality, morbidity, and cost associated with febrile neutropenia in adult cancer patients
NM Kuderer et al.
CANCER (2006)
Epidemiology and outcomes of serious influenza-related infections in the cancer population
CD Cooksley et al.
CANCER (2005)
Toxicity and efficacy of daily dapsone as Pneumocystis jiroveci prophylaxis after hematopoietic stem cell transplantation:: A case-control study
D Sangiolo et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2005)
Eradication of minimal residual disease in B-cell chronic lymphocytic leukemia after alemtuzumab therapy is associated with prolonged survival
P Moreton et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada)
SE Kidd et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Prevention of infection due to Pneumocystis spp. in human immunodeficiency virus-negative immunocompromised patients
M Rodriguez et al.
CLINICAL MICROBIOLOGY REVIEWS (2004)
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation
DJ Winston et al.
CLINICAL INFECTIOUS DISEASES (2003)
Recurrent Clostridium difficile colitis:: Case series involving 18 patients treated with donor stool administered via a nasogastric tube
J Aas et al.
CLINICAL INFECTIOUS DISEASES (2003)
Cytomegalovirus viremia during Campath-1H therapy for relapsed and refractory chronic lymphocytic leukemia and prolymphocytic leukemia
DD Nguyen et al.
CLINICAL LYMPHOMA (2002)
Impact of therapy with chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B 9011
VA Morrison et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study
S Bregante et al.
BONE MARROW TRANSPLANTATION (2000)
Share Paper
